Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

35.60p
   
  • Change Today:
    -3.40p
  • 52 Week High: 48.00p
  • 52 Week Low: 34.00p
  • Currency: UK Pounds
  • Shares Issued: 739.79m
  • Volume: 118,205
  • Market Cap: £263.37m
  • Beta: 0.48

Benchmark Holdings puts itself up for sale, shares jump

By Benjamin Chiou

Date: Monday 22 Jan 2024

LONDON (ShareCast) - (Sharecast News) - Shares in Benchmark Holdings jumped on Monday after the UK-listed aquaculture services group kickstarted a formal sales process
"The board believes that the current share price materially undervalues the combined value of Benchmark's businesses and the long-term prospects of the company, which may at least in part be due to the tightly held and illiquid nature of its ordinary shares," Benchmark said in a statement.

The company, which is a aquaculture genetics, nutrition, and health business, delivering biotechnology products and solutions to the aquaculture industry, said it is not yet in discussions with any parties and highlighted to shareholders that it cannot promise a sale would happen.

Benchmark Holdings floated on the AIM market in December 2013 but has seen its share price slide over 50% since then, even after Monday's 18% surge. The stock currently trades at 41.26p, giving a market capitalisation of just over £300m.

For its most recent financial year, ended 30 September 2023, Benchmark delivered 7% revenue growth, a 15% increase in adjusted EBITDA and improved its operational cash conversion from 35% to 58%, "demonstrating continued progress in the year despite challenging conditions in the shrimp sector, one of the company's core markets", it said.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

BMK Market Data

Currency UK Pounds
Share Price 35.60p
Change Today -3.40p
% Change -8.72 %
52 Week High 48.00p
52 Week Low 34.00p
Volume 118,205
Shares Issued 739.79m
Market Cap £263.37m
Beta 0.48

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average
32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average
Price Trend
32.77% below the market average32.77% below the market average32.77% below the market average32.77% below the market average32.77% below the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Income Not Available
Growth
10.03% above the market average10.03% above the market average10.03% above the market average10.03% above the market average10.03% above the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
13:45 3 @ 35.64p
12:40 44 @ 36.00p
11:41 5,682 @ 36.00p
11:41 6,318 @ 36.00p
11:38 7,236 @ 35.61p

BMK Key Personnel

Chair Peter George
CFO Septima Maguire
CEO Trond Williksen

Top of Page